'Adverse drug reactions' diaporamas de présentation

Treatment During Pregnancy: Gaps in our Knowledge

Treatment During Pregnancy: Gaps in our Knowledge Donald R Mattison Obstetric and Pediatric Pharmacology Research Branch Center for Research for Mothers and Children NICHD, NIH, HHS mattisod@mail.nih.gov 301 451 3823

1.51k views • 77 slides

Expedited Partner Therapy (EPT) for Gonorrhea & Chlamydial Infection

912 views • 60 slides

1.02k views • 56 slides

Reuse of Data Coded with High-Quality Terminologies: Practical Examples from Patient Care Settings

Reuse of Data Coded with High-Quality Terminologies: Practical Examples from Patient Care Settings. James J. Cimino, M.D. Department of Biomedical Informatics Columbia University College of Physicians and Surgeons. Case Presentation.

684 views • 53 slides

790 views • 46 slides

Bioinformatics: Impact on Health and Drug Development

1.03k views • 46 slides

The combination of low dose of naloxone and morphine in PCA

The combination of low dose of naloxone and morphine in PCA. 10/4 Morning Meeting Yu Chang Yeh. The combination of low dose of naloxone and morphine in PCA. Objective Backgrounds Patient selection and exclusion Standard setup. The combination of low dose of naloxone and morphine in PCA.

656 views • 45 slides

Genetically Individualized Therapies in Reducing Drug Toxicity

956 views • 43 slides

497 views • 41 slides

Diverse Disciplines in Chemistry

Diverse Disciplines in Chemistry. Medicinal Chemistry in the Practice of Pharmacy. Robin M. Zavod, PhD. First: Who is Sitting Next to You?. Dust off the Rust! Rev up the Brain Cells! Get the pie-hole working again! ICE BREAKER!

785 views • 40 slides

Genetic polymorphism: (i) individual handling of drugs (ii) inherited susceptibility to disease

Genetic polymorphism: (i) individual handling of drugs (ii) inherited susceptibility to disease. Much individuality in drug response is inherited (polymorphism). PHARMACOGENETICS. Identify specific genes associated with specific diseases and that may be targets for new drugs.

1.32k views • 39 slides

Management of Tuberculosis Patient in Hong Kong

Management of Tuberculosis Patient in Hong Kong. (10 December 2000). Medical conditions of patients at the time of developing TB (notified in August 1999) (Total no.= 594). One or more medical conditions 155 (26.09%) [Two medical conditions 16 (2.69%)] [Three medical conditions 2 (0.34%)]

812 views • 37 slides

Adverse Drug Events

Adverse Drug Events . Judith Coombes Neil Cottrell School of Pharmacy, University of Queensland. Objectives.

1.31k views • 35 slides

Psychiatric Adverse Events with Drug Treatments of ADHD

Psychiatric Adverse Events with Drug Treatments of ADHD. Review of Postmarketing Safety Data: Pediatric Population Kate Gelperin, M.D., M.P.H. FDA Office of Drug Safety Division of Drug Risk Evaluation. Points for discussion today:. Methods for case review and analysis

615 views • 33 slides

The management of adverse drug reactions I Ralph Edwards

The management of adverse drug reactions I Ralph Edwards. Diagnosis Procedures Management Therap y Often no clear separation. The management of adverse drug reactions. Is the patient taking drugs? OTC OC Herbal/traditional Abused drugs Long term prescription Check with medical history.

561 views • 28 slides

1.53k views • 27 slides

Monitoring Patients on Anti-TB Medications

Monitoring Patients on Anti-TB Medications. Reynard J. McDonald, MD Medical Director, Lattimore Practice Northeast National Tuberculosis Center at NJMS. Adverse Side Effect.

705 views • 26 slides

Calculating & Reporting Healthcare Statistics

Calculating & Reporting Healthcare Statistics. Second Edition Chapter 8 Morbidity and Other Miscellaneous Rates. Infections. Morbidity State of being diseased or the number of sick persons or cases of disease in relation to a specific population May be infectious or have other causes

1.49k views • 20 slides

Quiz

Quiz. Adverse Drug Reactions. Fill in the blanks. Adverse drug reactions are any noxious, __________, and __________ effect of a drug that occurs at doses used for prevention, diagnosis, or treatment. Type A reactions are _____________ reactions.

438 views • 12 slides

Reducing length of stay through medicines management interventions

Reducing length of stay through medicines management interventions. Key Slides.

280 views • 6 slides